Bupropion efficacy for smoking cessation is influenced by the "DRD2" Taq1A polymorphism: Analysis of pooled data from two clinical trials

Autor:	David, Sean P., Strong, David R., Munafò, Marcus R., Brown, Richard A., Lloyd-Richardson, Elizabeth E., Wileyto, Paul E., Evins, Eden A., Shields, Peter G., Lerman, Caryn, Niaura, Raymond
Zdroj:	Nicotine & Tobacco Research, 2007 Dec 01. 9(12), 1251-1257.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26762090 Zobrazit plný text záznamu